RWD osmotic pump is a precise drug delivery tool. Usually, 3 days, 1 week, and 2 weeks dosing a slow-release pump requires 6-8, 12-24, 24-48 hours of incubation, after which the slow-release pump can administer the drug at a constant rate (within a predictable range). The liquid pump is released until only about 5% of the solution remains in the storage tank, and then the rate drops to zero. The method RWD uses to estimate the pumping rate of the osmotic pump is to measure the pumping rate of the slow-release pump in 37% (± 0.5°C) 0.9% saline in vitro. This in vitro test method has good reproducibility, whether it is the test of the same batch of slow-release pumps or different batches of slow-release pumps at different periods, and is used to estimate the pump's expected pumping rate. For example, in rats and mice, the deviation of the subcutaneous or intraperitoneal pumping rate of the implanted micro sustained-release pump from the in vitro rate is within 5%.
The catheter can be introduced into different sites, such as the cranial cavity and spinal cord, intravascular, liver, spleen, and other organs and trauma.
Features:
RWD osmotic pump is a precise drug delivery tool. Usually, 3 days, 1 week, and 2 weeks dosing a slow-release pump requires 6-8, 12-24, 24-48 hours of incubation, after which the slow-release pump can administer the drug at a constant rate (within a predictable range). The liquid pump is released until only about 5% of the solution remains in the storage tank, and then the rate drops to zero. The method RWD uses to estimate the pumping rate of the osmotic pump is to measure the pumping rate of the slow-release pump in 37% (± 0.5°C) 0.9% saline in vitro. This in vitro test method has good reproducibility, whether it is the test of the same batch of slow-release pumps or different batches of slow-release pumps at different periods, and is used to estimate the pump's expected pumping rate. For example, in rats and mice, the deviation of the subcutaneous or intraperitoneal pumping rate of the implanted micro sustained-release pump from the in vitro rate is within 5%.
The catheter can be introduced into different sites, such as the cranial cavity and spinal cord, intravascular, liver, spleen, and other organs and trauma.
Features:
Do you have comments? Please to post comments here!